Opus Genetics, Inc.

Opus Genetics, Inc. financial statements

Opus Genetics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 14.2M10-K
Net income−USD 49.59M10-K
Cash and equivalentsUSD 45.09M10-Q
Total debtUSD 1.13M10-Q

Opus Genetics, Inc. financials on 6ix · Opus Genetics, Inc. on 6ix